SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is a hot topic following its record December and Q4 vehicle deliveries, which are igniting bullish sentiment around the company's path to profitability and expansion with new brands like ONVO and Firefly. Despite strong operational performance and nearing one million cumulative deliveries, many investors are debating perceived market manipulation and the stock's valuation compared to rivals. This positions NIO as a focal point for discussions on growth versus market dynamics in the EV sector.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is trending as a leader in real-world asset tokenization, evidenced by major partnerships with traditional finance players and recent institutional interest following a spot ETF launch. The community views LINK as a long-term utility play, further bolstered by ongoing token accumulation and its proven role as crucial cross-chain infrastructure.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending with highly polarized sentiment as the new trading year begins, following recent declines attributed to year-end profit-taking. While many anticipate a strong rebound and "full breakout mode" for the tech-heavy index, others warn of "massive dumps" and increased volatility, citing bearish technicals and concerns about the broader economic landscape and AI sector. The community is actively debating whether QQQ will continue its impressive run or face a significant correction.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is actively trending as its AI chip unit, Kunlunxin, prepares for a potential IPO, generating significant buzz around its role in addressing China's domestic AI chip demand. Community discussions are highlighting the global expansion of its Apollo Go robotaxi service through major partnerships and the reported adoption of Baidu's chips by other AI firms, collectively driving a narrative of the company's strong growth trajectory in autonomous driving and AI infrastructure.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe Coin is actively trending amidst strong bullish sentiment across the crypto market, with its community enthusiastically discussing predictions of dropping zeros and even reaching significant price points. Despite some skepticism regarding its fundamentals and large supply, many investors are embracing its meme coin status as a high-risk, high-reward opportunity, fueled by broader 'alt season' narratives.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad (MON) is trending amid recent positive attention from major financial news and robust on-chain growth metrics, including a rapid increase in new wallets and ecosystem integrations. The community is actively debating its potential as a high-performance EVM blockchain and long-term crypto asset, while some express skepticism regarding its tokenomics and have raised concerns about its valuation.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust (SPY) is trending with strong upward momentum in futures, driven by the perceived conclusion of tax loss selling and a significant Fed liquidity injection. Community sentiment is sharply divided, with bulls anticipating a continued rally into the new year, while bears warn of a potential bull trap and heightened volatility ahead. The broader market conversation also encompasses the sustained impact of AI demand and global economic indicators.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is trending following a strategic manufacturing partnership announcement, which many believe positions the company for significant growth and increased production capacity. This news is fueling speculative interest and comparisons to previous low-float movers. However, community discussion is sharply divided, with others expressing apprehension about substantial dilution from a recently disclosed private placement.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending amid an intense debate regarding potential supply shortages, notably fueled by new export restrictions from a major silver-producing nation. Many in the community anticipate an unprecedented "silver squeeze" and a decoupling of physical and paper prices, while others warn it's a speculative bubble ripe for a significant market correction. This volatility, often linked to increased margin requirements from major exchanges, is intensifying discussions around market manipulation and silver's true market value.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is a top trending stock following reports of overwhelming demand for its H200 AI chips from major Chinese technology companies, prompting requests for increased production from TSMC. The community is highly bullish, actively discussing potential strategic acquisitions in AI inference and eagerly awaiting new product roadmaps expected at CES 2026, despite some debate over recent price fluctuations. This reinforces NVIDIA's central role in the global AI infrastructure build-out.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best Biotech Stocks To Follow Now - January 1st

Vertex Pharmaceuticals, Danaher, Abivax, Moderna, and United Therapeutics are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of...

VIRGINIA RETIREMENT SYSTEMS ET Al Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX

VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the third quarter, according to its most recent filing with the...

25,734 Shares in Vertex Pharmaceuticals Incorporated $VRTX Bought by Generate Investment Management Ltd

Generate Investment Management Ltd bought a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 3rd quarter, according to its most recent filing with the...

Ethic Inc. Has $5.47 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX

Ethic Inc. boosted its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 21.5% during the third quarter, according to the company in its most recent filing with...

Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $453.74, marking a -1.31% move from the previous day.

Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Best Biotech Stocks To Consider - December 29th

Danaher, Vertex Pharmaceuticals, and Abivax are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that...

Leerink Partners Boosts Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $525.00

Leerink Partners lifted their price objective on Vertex Pharmaceuticals from $456.00 to $525.00 and gave the stock an "outperform" rating in a report on Monday...

Best Biotech Stocks To Follow Now - December 28th

Danaher, Moderna, Vertex Pharmaceuticals, Cidara Therapeutics, United Therapeutics, Medpace, and argenex are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...

Burney Co. Reduces Position in Vertex Pharmaceuticals Incorporated $VRTX

Burney Co. cut its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 83.1% during the third quarter, according to the company in its most recent Form 13F filing with the...

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$5.12	--	--	N/A
Q3 '25	$4.58	$4.80	4.91%	BEAT
Q2 '25	$4.27	$4.52	5.80%	BEAT
Q1 '25	$4.25	$4.06	-4.37%	MISSED
Q4 '24	$4.02	$3.98	-0.90%	MISSED

VRTX
Vertex Pharmaceuticals, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest VRTX News

VRTXVertex Pharmaceuticals, Inc.